Identification of prognostic factors predicting outcome in Hodgkin's lymphoma patients relapsing after autologous stem cell transplantation
Carmen Martı́nez(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Anna Sureda(Institut d'Investigació Biomédica de Bellvitge), Luca Castagna(Humanitas University), John A. Snowden(Sheffield Teaching Hospitals NHS Foundation Trust), Nöel Milpied(Hôpital Cardiologique du Haut-Lévêque), Alberto Bosi(Azienda Ospedaliero-Universitaria Careggi), Rosi Oneto(Gruppo Italiano per il Trapianto di Midollo Osseo), Andrzej Hellmann(Gdańsk Medical University), Rein Willemze(Leiden University Medical Center), Carmen Canals(Hospital de Sant Pau), Simona Sica(San Antonio College), Cármino Antônio De Souza(Universidade Estadual de Campinas (UNICAMP)), Barbara Sarina(IRCCS Humanitas Research Hospital), Alessandro Pulsoni(Ospedale Santa Maria Goretti), Peter Dreger(Heidelberg University), Marek Trněný(Charles University), David Sibon(Hôpital Necker-Enfants Malades), S. Guidi(Gruppo Italiano per il Trapianto di Midollo Osseo), E. P. Alessandrino(Istituti di Ricovero e Cura a Carattere Scientifico), R. Arranz(Hospital Universitario de La Princesa), Edward Kanfer(University of Washington Medical Center), Dimitrios Karakasis(Evangelismos Hospital), J.J. Luan(Hôpital Claude Huriez), Ladislav Jebavý(Charles University)
Cited by 105
Related Papers
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Guidelines for the diagnosis and management of adult aplastic anaemia
|British Journal of Haematology|2015|750